Thomson Reuters Launches Thomson Pharma Partnering Forecast

PHILADELPHIA and LONDON , Sept. 21 /CNW/ - Thomson Reuters today launched Thomson Pharma Partnering Forecast, a new product that provides a unique combination of competitive intelligence and sales forecast data to enable quick and credible assessment of the sales potential of pipeline and marketed drugs. The product will be demonstrated at two upcoming conferences: Pharma Forecasting Excellence USA in Boston on October 8 and 9, and Bio Europe 2009 in Vienna from November 2 to 4.

"Our customers tell us that they must do sales forecasts more quickly and more often than ever before," said Jon Brett Harris , executive vice president of life science at Thomson Reuters. "We are pleased to offer the first information product to combine market-based and patient-based forecasts. This combination of data points will enable our customers to quickly create credible forecasts on a drug's potential."

Thomson Pharma Partnering Forecast contains a consensus of analyst forecasts for strategic drugs across the major pharma therapy areas, and combines these forecasts with downloadable, patient-based revenue models for drugs in over 100 indications. The models include transparent assumptions on incidence and prevalence, eligible numbers of patients, estimated timing of approval, pricing, and market share within the indication. The data is linked with the industry's most trusted source of intelligence on the industry pipeline, allowing customers to assess the competitive position of a drug and quickly forecast its sales potential. The product combines data captured from Thomson Reuters own drug monitoring team, including assessments of multiple analyst forecasts, and integrates it with drug assessments, patient-based forecasts and approval timelines licensed from its recently announced partnership with BioMedTracker.

For more information on Thomson Pharma Partnering Forecast, please visit http://go.thomsonreuters.com/forecast.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.

For further information: Susan Besaw, Healthcare & Science, [phone], [email protected], Web Site: http://www.thomsonreuters.com